Mizuho raises GE HealthCare stock price target to $90 on growth
Mizuho raised its price target for GE HealthCare (GEHC) to $90 from $85, citing 6% organic growth and stable demand for imaging capital. The stock trades at $75.82. GEHC reported Q3 2026 revenue of $5.5B, 6.2% organic growth, and raised its full-year outlook. Stifel and BofA also updated their price targets.
How this was made
The 30-second read
Why it matters
The combination of higher earnings and upgraded targets creates a bullish catalyst for GEHC.
Market read
GEHC's earnings beat and multiple target upgrades provide a clear short‑term upside catalyst.
What to watch
Potential headwinds from Middle East conflict and Medicaid cuts could temper growth.
Background
The article combines analyst price‑target upgrades with the company's Q3 earnings release.
Ticker impact
Mizuho raised its price target on GE HealthCare to $90 and reported Q3 2026 earnings with $5.5B revenue and 25.1% EPS growth.
likely upward pressure as the market prices in higher earnings and target raises
Target hikes from multiple analysts and better‑than‑expected results provide a clear catalyst for price appreciation.
Market effects
Strong results may lift other medical‑technology and imaging equipment stocks.
U.S. healthcare sector could see modest gains.
Reinforces confidence in global hospital‑capital spending trends.
Counterpoint
If the PCS segment underperforms, the price targets may be overly optimistic.
Key entities
- AnalystMizuho
Raised GEHC price target to $90.
- AnalystStifel
Raised price target to $90.
- AnalystBofA Securities
Raised price target to $84.
